Collectively, our focused CRISPR screening, along with the DepMap and ZNF217 expression results, underscores the indispensable role of ZNF217 in the survival/proliferation of human B-ALL cells. This evidence concerns the gene ZNF217 and acute lymphoblastic leukemia.